Clinical Trial Detail

NCT ID NCT04441138
Title Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC (ESR1814205)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rush University Medical Center
Indications

lung non-small cell carcinoma

Therapies

Durvalumab

Age Groups: adult senior

No variant requirements are available.